Cedars-Sinai Technology Ventures

Yesterday we welcomed a delegation of inspiring Italian women-led startups in health tech and green tech. Organized by Nuleep and the Italian Trade Agency, and US Market Access, this gathering brought together visionaries dedicated to advancing healthcare and sustainability. The event featured an interactive roundtable discussion on the future of health tech and sustainable innovation, with invaluable insights from industry leaders and startup founders. This was more than just a meeting—it was a glimpse into the future of healthcare and sustainability, with global perspectives and collaborative energy driving meaningful conversations. A heartfelt thank you to our partners The Italian Trade Agency - Los Angeles Office, particularly Sebastiano Peluso, Stefano Reppucci, @Alfredo Coppola, and Grace Park, for their exceptional support and dedication through the #GlobalStartupProgram. Their commitment to fostering international connections was instrumental in bringing these groundbreaking ideas to our community. Thank you to our Cedars-Sinai team for their invaluable contributions: ? Sean Collins, Executive Director of Facilities Planning, Design and Construction, Cedars-Sinai ? Erin Jackson-Ward, DrPH, Executive Director, Grantmaking and Social Impact ? Mark Rojas, Executive Director, Plant Operations and Engineering Services ? Julien Brohan, Manager, Business Development and Licensing, Cedars-Sinai Technology Ventures ? Wenyue Du, PhD, CLP, Manager, Business Development and Licensing, Cedars-Sinai Technology Ventures ? Emily Mack, Program Manager, Global Alliances, Cedars-Sinai Technology Ventures ? Michael Adame, Program Coordinator, Cedars-Sinai Technology Ventures ? Rithik Jain, Startup Recruitment Lead, Cedars-Sinai Accelerator

Congratulations to everyone – your achievements speak for themselves, and we couldn’t have said it better!

As the The Cedars-Sinai Accelerator approaches the conclusion of their Class 10 program, the Cedars-Sinai Technology Ventures team congratulates them for their dedication.?Cedars-Sinai Technology Ventures is proud to have contributed and offered insights to help guide these 10 very promising companies. We extend our gratitude to Kinshuk Kocher, manager of investments and special projects, Julien Brohan, manager of business development and licensing, and Nirdesh K Gupta, PhD, Managing Director, Cedars-Sinai Technology Ventures, whose relentless efforts in one-on-one sessions have been instrumental in driving these startups forward. Additionally, to Wenyue Du, PhD, CLP, manager of business development and licensing, for moderating the session, "Innovation to Impact: Advancing Healthcare through Cedars-Sinai Research and Clinical Trials."?? ?As we continue to build momentum, all eyes are on Demo Day at HLTH USA where we look forward to showcasing the future of healthcare innovation. We hope to see you there!

Introducing Cedars-Sinai Technology Ventures: The Spectrum of Innovation Brochure. We are proud to unveil our latest initiative that embodies our commitment to advancing healthcare through cutting-edge innovation. The Spectrum of Innovation brochure highlights our focus on groundbreaking medical technologies that have the potential to revolutionize healthcare and significantly improve patient outcomes. Globally, life expectancy has more than doubled in the last 200 years. This extraordinary progress is due not only to socio-economic advancements but also to remarkable innovations in medicine. At Cedars-Sinai Technology Ventures, we are dedicated to driving forward these innovations—precision medicine, genome editing, nanomedicine, regenerative medicine, and mRNA vaccines—along with emerging fields like virtual reality, augmented reality, and generative AI. Our investments in forward-thinking biomedical science along the entire spectrum of innovation are aimed at transforming ideas into healing, ultimately contributing to longer, healthier lives. This is our mission. This is our vision. Explore how we are shaping the future of healthcare in our new Spectrum of Innovation brochure. Together, we can transform the landscape of medicine.

Congratulations to?Aevice Health?on successfully closing their Seed Plus round, with significant participation from Coronet Ventures, our Singapore-based investment fund. This US$7 million investment is a pivotal step towards their success. Cedars-Sinai Technology Ventures?is excited to support?Aevice Health’s team through various initiatives that will engage key stakeholders across Cedars-Sinai, including?Dr. Irina Dralyuk?from?Guerin Children’s,?Colin Tan?from Coronet Ventures, and?Jian Tajbakhsh, PhD,?Omar Perez, and?Julien Brohan?from?Cedars-Sinai Technology Ventures. We look forward to collaborating closely to advance the management of chronic respiratory diseases. A special thanks to all the participating investors—Coronet Ventures,?East Ventures,?SEEDS Capital,?A&D Company,?NTUitive,?Farquhar VC (FVC), and?@Silicon Solution Partners—for their commitment to this shared vision.

We are excited to share that the Elevate HealthTech US Program with A*STAR - Agency for Science, Technology and Research and A*StartCentral has successfully concluded! The closing session took place on June 28, 2024 (Singapore time), during which the participating companies presented their refined go-to-market strategies for the US: Carecam Cogniant FathomX Health BETA HiCura Medical Pte Ltd iota medtech Kinexcs Magloy Tech Meracle NalaGenetics NDR Medical Technology Pte Ltd TIIM Healthcare Since our last update, we have completed the remaining sessions of the program, featuring insights from six additional speakers. We are incredibly grateful to the following guest speakers for their invaluable contributions: Jason H. Moore, PhD, FACMI, FIAHSI, FASA Tricia Ross Pearce Keren Dunn Robin McCaffery Brett Moodie Seth Levy Patrick Callaghan These sessions have further equipped our cohort with the knowledge and connections needed to thrive in the US market. The companies have demonstrated remarkable growth and adaptability, and we are hopeful and confident in their future success. We also extend our sincere thanks to the clinicians who generously met with the companies to offer their guidance and expertise. Their practical insights and mentorship have been instrumental in shaping the strategic directions of these startups. Our heartfelt thanks go out to the dedicated teams at Cedars-Sinai Technology Ventures, The Cedars-Sinai Accelerator, and A*STAR - Agency for Science, Technology and Research who made this program possible. Special recognition goes to Irene Cheong, Nirdesh K Gupta, PhD, Mayank Gurnani, MD MBA MSc, Julien Brohan, Asfa Alli Shaik, Carol Yew, Anthony Chong, Alex Choh, Samantha Shobash, Melieka Fathi, MPH and Omar Perez for their unwavering support and hard work. As we look to the future, we are optimistic about the impact these innovative health tech startups will have in the US healthcare landscape. We will continue to support and follow their journeys with great anticipation and pride. Stay tuned for more updates and success stories from these promising companies!

Last week, we had the honor of hosting senior leadership from SingHealth at Cedars-Sinai. The visit featured a comprehensive agenda designed to share best practices between two renowned international health systems. The day began with an overview of Cedars-Sinai’s innovation-focused programs by Dr. Nirdesh K Gupta, PhD , Managing Director, Cedars-Sinai Technology Ventures, followed by a collaborative discussion on various topics led by Dr. Jeffrey Golden, Cedars-Sinai Executive Vice Dean of Research and Education, and Edward Prunchunas Executive Consultant and former CFO of Cedars-Sinai Medical Center. Following this, Peter Park hosted a profound tour of the Cedars-Sinai Biomanufacturing Center. The delegation then visited the Medically Associated Science and Technology (MAST) program, where they met with Dr. Mark Pimentel for an in-depth look at their latest advancements. We extend our gratitude to the SingHealth delegation: -Mr. Cheng Wai Keung, Chairman -Prof. Tsun-yan Hsieh Board Member -Mr. Oon Jin YEOH Member -Ms. Wai Leng Chong Board Member -Prof. Ng Wai Hoe NG GEO -Prof. Kenneth Kwek DGCEO (Digital Health) -Prof. Soon Thye LIM DGCEO (Research, Education & Innovation) -Prof. Say Beng Tan Group Chief Research Officer -Ms. Enny Kiesworo Group Director, Research (Corporate Admin & Technology Development) -Prof. Aung Tin, Group Director, Research (Scientific) -Mr. Sia Kheng Hong, Senior Director & Joint Company Secretary -Dr. Danny B. Director, Technology Incubator (SCOUT) -Dr. Whye-Kei Lye , Director, SingHealth Intellectual Property -Ms. Siew Ying Koh Senior Manager, Technology Incubator (SCOUT) This visit would not have been possible without the support of our exceptional Cedars-Sinai Technology Ventures and The Cedars-Sinai Accelerator teams: -Edward Prunchunas Executive Consultant and former CFO, Cedars-Sinai Medical Center -Dr. Jeffrey Golden, Executive Vice Dean, Research and Education, Cedars-Sinai Medical Center -Dr. Nirdesh K Gupta, PhD , Managing Director, Cedars-Sinai Technology Ventures -Dr. Mark Pimentel Executive Director, MAST Program -Peter Park, Director, Business Operations, Cedars-Sinai Biomanufacturing Center -Dhruv Sareen, Executive Director Cedars-Sinai Biomanufacturing and Associate professor -Julien Brohan , Manager, Business Development & Licensing, Cedars-Sinai Technology Ventures -Wenyue Du, PhD, CLP , Manager, Business Development & Licensing, Cedars-Sinai Technology Ventures -Samantha Shobash, Manager, Cedars-Sinai Accelerator -Emily Mack, Program Manager, Global Alliances, Cedars-Sinai Technology Ventures -Michael Adame, Program/Project Coordinator, Cedars-Sinai Technology Ventures Thank you to all who contributed to making this visit a success.

Last week, our leadership team, Jim Laur and Nirdesh K Gupta, PhD , joined the Cedars-Sinai Accelerator team and alumni companies at HLTH Europe. We extend a special thank you to Jeffrey Golden, Cedars-Sinai Executive Vice Dean of Research and Education, for his participation and invaluable contributions to this trip. This new conference in the heart of Europe provided a fantastic opportunity to connect with our international partners, strengthen relationships, and explore new opportunities for global collaborations. #hltheuro

The ClavystBio team, including Khoo Shih , @Wen Qi Ho, Charles Yiliu Zhang, and Ning Mao, continued their journey last week with a visit to our The Cedars-Sinai Accelerator office. They learned about our ongoing initiatives at Cedars-Sinai Technology Ventures and explored our Accelerator programs. Additionally, they experienced an exceptional tour of the cutting-edge Cedars-Sinai Biomanufacturing Center. This visit wouldn't have been possible without the incredible efforts of our team in organizing and hosting, including Wenyue Du, PhD, CLP, Julien Brohan, Emily Mack, Peter Park, Omar Perez, Rithik Jain, Michael Adame, Raj Khandwalla MD MA FACC, Dann Peddy, and many others. Your hard work and dedication made this visit a resounding success!

Last evening, we had the opportunity to host our international and industry partners for a successful night of networking, engaging conversations, and delightful bites at the Bio International Convention 2024. #bio2024 National Health Innovation Centre (NHIC) Pauline Erica Tay A*STAR - Agency for Science, Technology and Research Daphne Wong ClavystBio Cedars-Sinai Biomanufacturing Center